コーパス検索結果 (１語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 plement regulatory protein CD55 (also termed decay-accelerating factor).
2 membrane complement regulatory protein CD55 (decay-accelerating factor).
3 the phosphatidylinositol linkage domain from decay accelerating factor.
4 lated adhesins recognize the common receptor decay accelerating factor.
5 , whereas CB1, CB3, and CB5 may also bind to decay accelerating factor.
6 acting with a complement-regulatory protein, decay-accelerating factor.
7 ent-regulatory proteins human CD59 and human decay-accelerating factor.
8 phosphatidylinositol (GPI) anchor from human decay-accelerating factor.
9 merization with the GPI signal sequence from decay-accelerating factor.
10 n of complement inhibitory proteins CD59 and decay-accelerating factor.
11 to display a reduced capacity for clustering decay-accelerating factor.
12 membrane cofactor protein were swapped into decay-accelerating factor.
15 ered truncations and molecular chimeras with decay-accelerating factor, a related protein in the fami
16 hearts from transgenic pigs expressing human decay-accelerating factor and CD59 underwent acute vascu
17 51 of CD14 fused to the C-terminal region of decay-accelerating factor and expressed it in Chinese ha
18 e C3 convertase, even after decay induced by decay-accelerating factor and factor H, as assayed by su
19 al analog of the human complement inhibitors decay-accelerating factor and membrane cofactor protein.
20 ell as to the complement-regulatory proteins decay-accelerating factor and membrane cofactor protein.
22 ibitors (C' receptor-1 related isoform Y and decay accelerating factor), and an increase in local TUN
23 nitiates immune evasion through induction of decay accelerating factor, and transactivates peroxisome
24 ines was correlated with low levels of CD59, decay-accelerating factor, and membrane cofactor protein
25 reported that E. coli Dr adhesin recognizes decay-accelerating factor as the host tissue receptor an
26 y, the four short consensus repeats of human decay accelerating factor (CD55) linked to IgG4 Fc and t
27 hypothesis that increasing the expression of decay accelerating factor (CD55) on RPE cells may result
32 activation pathway, as well as mice lacking decay-accelerating factor (CD55/DAF), a complement regul
33 om known decay accelerating factors, such as decay accelerating factor, complement receptor 1, and fa
34 boons received xenotransplants of both human decay-accelerating factor composite thymokidneys and ome
36 he membrane co-factor protein (MCP or CD46), decay accelerating factor (DAF or CD55) and CD59, indica
37 reas in .48 transfectants the GPI anchors in decay accelerating factor (DAF) and placental alkaline p
40 plement system and adaptive immunity is that decay accelerating factor (DAF), a cell surface C3/C5 co
41 e short consensus repeat-3 (SCR-3) domain of decay accelerating factor (DAF), a complement regulatory
42 lpha chain, membrane cofactor protein (MCP), decay accelerating factor (DAF), and complement receptor
43 icient in the complement regulatory protein, decay accelerating factor (DAF), and/or the complement c
44 Complement-activation controllers, including decay accelerating factor (DAF), are gaining emphasis as
45 hough many coxsackie B viruses interact with decay accelerating factor (DAF), attachment to DAF by it
46 in 2, cbp/p300-interacting transactivator 2, decay accelerating factor (DAF), vascular cell adhesion
48 soluble chimeric protein derived from human decay accelerating factor (DAF, CD55) and membrane cofac
49 ciency of the complement inhibitory proteins decay accelerating factor (DAF, CD55) and membrane inhib
50 ing sites for factors B, H and I, properdin, decay accelerating factor (DAF, CD55), membrane cofactor
51 eptor type 1 (CR1, CD35: Knops antigens) and decay accelerating factor (DAF, CD55: Cromer antigens).
52 e cognate receptors of live virions, namely, decay accelerating factor (DAF/CD55) expressed on Tanoue
54 rotein possessing the functions of the human decay-accelerating factor (DAF [CD55]) and membrane cofa
57 tween echovirus 11 strain 207 (EV11-207) and decay-accelerating factor (DAF or CD55) at the apical su
61 tudy we investigated whether the presence of decay-accelerating factor (DAF or CD55), an intrinsic co
63 ediated cleavage of C3b into iC3b as well as decay-accelerating factor (DAF) activity against the C3
64 enic, and adhesive subunit, which recognizes decay-accelerating factor (DAF) and carcinoembryonic ant
65 ns adheres to epithelial cells by binding to decay-accelerating factor (DAF) and carcinoembryonic ant
67 We previously developed a renal IRI model in decay-accelerating factor (DAF) and CD59 double-knockout
69 (EV) and Coxsackie B virus (CBV) bind human decay-accelerating factor (DAF) and use it as a receptor
70 receptor 1-related gene/protein y (Crry) and decay-accelerating factor (DAF) are two murine membrane
71 f invading epithelial cells recognizes human decay-accelerating factor (DAF) as its cellular receptor
74 oxsackievirus B (CVB) isolates bind to human decay-accelerating factor (DAF) as well as to the coxsac
75 Many coxsackievirus B isolates bind to human decay-accelerating factor (DAF) as well as to the coxsac
76 B entry into placental trophoblasts requires decay-accelerating factor (DAF) binding and involves rel
78 ecreased membrane cofactor protein (MCP) and decay-accelerating factor (DAF) expression on endothelia
81 coxsackievirus-adenovirus receptor (CAR) and decay-accelerating factor (DAF) have been identified as
82 lecule that binds into the viral canyon, and decay-accelerating factor (DAF) have been identified as
90 (GPI)-anchored complement regulatory protein decay-accelerating factor (DAF) is used by a number of e
91 have evaluated the effect of the absence of decay-accelerating factor (DAF) on cardiac allograft rej
93 and diarrhoea-associated Escherichia coli to decay-accelerating factor (DAF) present on erythrocytes
94 ent vasculoprotective pathway, which induced decay-accelerating factor (DAF) promoter activity via bi
96 DAA and CFA by constructing chimeras of the decay-accelerating factor (DAF) that exhibits DAA and me
98 ave isolated a murine homologue of the human decay-accelerating factor (DAF), a glycosylphosphatidyli
101 nto the mucosal surface by goblet cells, and decay-accelerating factor (DAF), a protein produced by c
103 B3 (CVB3) depends on virus interaction with decay-accelerating factor (DAF), a receptor expressed on
104 s revealed that the endogenous expression of decay-accelerating factor (DAF), an inhibitor of complem
105 epletion of membrane cofactor protein (MCP), decay-accelerating factor (DAF), and CD59 on inhibitory
106 E-associated complement receptor 1 (CR1) and decay-accelerating factor (DAF), and pronounced splenic
107 d versions of the human complement inhibitor decay-accelerating factor (DAF), as a fusion protein fro
108 the cell surface C3/C5 convertase inhibitor decay-accelerating factor (DAF), but not the combined ab
109 e deficient in the key complement regulator, decay-accelerating factor (DAF), but not WT or CD59-defi
111 he distribution of the complement inhibitors decay-accelerating factor (DAF), CD59 (protectin), and m
112 Although the complement-regulatory proteins decay-accelerating factor (DAF), CD59, and membrane cofa
114 ) of these central enzymes by the regulators decay-accelerating factor (DAF), complement receptor 1 (
116 reated with atorvastatin or simvastatin, and decay-accelerating factor (DAF), membrane cofactor prote
118 tor 1-related gene/protein y (Crry), but not decay-accelerating factor (DAF), were spontaneously elim
119 a cDNA coding for the last 37 amino acids of decay-accelerating factor (DAF), which contains the sign
129 ease in some patients to deficiency of CD55 [decay-accelerating factor (DAF)], but the mechanism unde
130 pression on chromosome 1 were those encoding decay-accelerating factor (DAF, also known as CD55) and
133 iridae family, uses the complement regulator decay-accelerating factor (DAF, CD55) as a cellular rece
136 (CCP) modules of the cell surface regulator, decay-accelerating factor (DAF, CD55), comprise the simp
138 program, GC B cells repressed expression of decay-accelerating factor (DAF/CD55) and other complemen
139 Here, we show that podocyte expression of decay-accelerating factor (DAF/CD55), a complement C3 co
142 icited IgM Ab but no other isotypes, whereas decay accelerating factor (Daf1)(-/-) mice elicited more
143 rast, CD4-deficient chimeric mice possessing decay accelerating factor deficient (Daf1(-/-)) bone mar
144 , under the direction of the GPI signal from decay accelerating factor, directs hGH cell surface expr
145 in which low levels of human CD59 and human decay-accelerating factor expression significantly effec
146 on of CD59 was up-regulated by 100%, whereas decay-accelerating factor expression was unchanged.
147 , src, hck, CD4, CD45, G proteins, and CD55 (decay-accelerating factor) expression in the buoyant low
148 three natural complement regulatory proteins decay accelerating factor, factor H and complement recep
149 vesicles also showed enrichment of albumin, decay-accelerating factor, Fc gammaRIII, and CR3; wherea
150 rm survival of nonhuman primates using human decay-accelerating factor (hDAF) transgenic pig organs a
151 miniature swine or pigs transgenic for human decay-accelerating factor (hDAF) were transplanted into
152 c for a human complement regulatory protein, decay-accelerating factor (hDAF), were major advances.
154 3; mTOR, mammalian target of rapamycin; DAF, decay-accelerating factor; IKK, IkappaB kinase; IRF, int
155 expressing adhesins of the Dr family bind to decay-accelerating factor, invade epithelial cells, pref
156 dicates that interaction of Dr fimbriae with decay-accelerating factor is associated with redistribut
157 or density, and in situ hybridization of Dr (decaying-accelerating factor) ligands for Escherichia co
158 H2-terminal short consensus repeats of human decay accelerating factor linked to IgG2 Fc have been de
159 NADPH oxidase activity, whereas VEGF-induced decay-accelerating factor-mediated protection of endothe
160 o up-regulation of the complement regulators decay accelerating factor, membrane cofactor protein, an
161 e fimbriated and others afimbriated, bind to decay-accelerating factor molecules on human cells.
164 forms of either membrane cofactor protein or decay-accelerating factor or of both factors combined.
166 mplex-inbred miniature swine (n=7) and human decay-accelerating factor pigs (n=3) were transplanted i
168 s strategy allowed CFA to be introduced into decay-accelerating factor, suggesting that viral and hum
169 llular domain of an apical membrane protein, decay accelerating factor, to the basolateral membrane.
170 /-)) or homozygous (hDAF(+/+)) for the human decay accelerating factor transgene (hDAF) or their nont
171 f xenografts in baboon recipients from human decay-accelerating factor transgenic or alpha-1,3-galact
173 nd kidney (composite thymokidney) from human decay accelerating factor-transgenic swine were transpla
174 his model, the kidney xenografts, from human decay accelerating factor-transgenic swine, in baboons u
177 ity for echovirus 11 of various fragments of decay-accelerating factor, we are able to conclude that
179 lls, cultured from pigs transgenic for human decay accelerating factor, were treated with human tumor
180 We found that disabling CD55 (also known as decay accelerating factor), which lifts restraint on aut
181 unction mutations in the gene encoding CD55 (decay-accelerating factor), which lead to loss of protei
182 D2B muscle exhibited decreased expression of decay accelerating factor, which was not dysferlin-speci
183 the use of donor organs transgenic for human decay-accelerating factor (with organ survival up to 2 m
184 nts of renal xenografts transgenic for human decay-accelerating factor, with survival between 4 and 6